Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klemens Budde

Showing results (11-20 of 502) with videos related to

Pageof 51
Sort By:
Transplantation|February 21, 2012
About incidence and timing of donor-specific antibodies after graft nephrectomyKlemens Budde, Michael Dürr
Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2010
Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize riskLutz Liefeldt, Klemens Budde
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 2015
Current status of immunosuppressive minimization and tolerance strategiesSophie Brouard, Klemens Budde
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem?Markus Giessing, Klemens Budde
Nature Reviews. Nephrology|October 3, 2012
Transplantation: Sirolimus for secondary SCC prevention in renal transplantationFabian Halleck, Klemens Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2023
Stronger together: Lessons from the iBox qualification processKlemens Budde, Bruce Kaplan
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Back to the Future With Co-Stimulation BlockadeStuart M Flechner, Klemens Budde
Kidney International|August 22, 2025
Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving fieldGeorg A Böhmig, Klemens Budde
Clinical and Experimental Nephrology|November 27, 2014
Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Gerd Walz
Transplant International : Official Journal of the European Society for Organ Transplantation|August 14, 2013
Frequency and long-term outcomes of post-transplant hypophosphatemia after kidney transplantationLu Huber, Marcel Naik, Klemens Budde
Pageof 51

Showing results (11-20 of 502) with videos related to

Sort By:
Pageof 51
Transplantation|February 21, 2012
About incidence and timing of donor-specific antibodies after graft nephrectomyKlemens Budde, Michael Dürr
Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2010
Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize riskLutz Liefeldt, Klemens Budde
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 2015
Current status of immunosuppressive minimization and tolerance strategiesSophie Brouard, Klemens Budde
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem?Markus Giessing, Klemens Budde
Nature Reviews. Nephrology|October 3, 2012
Transplantation: Sirolimus for secondary SCC prevention in renal transplantationFabian Halleck, Klemens Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2023
Stronger together: Lessons from the iBox qualification processKlemens Budde, Bruce Kaplan
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Back to the Future With Co-Stimulation BlockadeStuart M Flechner, Klemens Budde
Kidney International|August 22, 2025
Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving fieldGeorg A Böhmig, Klemens Budde
Clinical and Experimental Nephrology|November 27, 2014
Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Gerd Walz
Transplant International : Official Journal of the European Society for Organ Transplantation|August 14, 2013
Frequency and long-term outcomes of post-transplant hypophosphatemia after kidney transplantationLu Huber, Marcel Naik, Klemens Budde
Pageof 51